Neuralink

Neuralink is a neurotechnology company founded by Elon Musk in 2016 that is developing implantable brain-computer interfaces (BCIs) aimed at enabling direct communication between the human brain and computers.

The N1 Implant

• Design: A small, coin-sized device implanted flush with the skull surface. Contains a chip that processes neural signals wirelessly — no external wires.
• Threads: 1,024 electrodes distributed across 64 ultra-thin, flexible threads (thinner than a human hair) inserted into the brain cortex.
• Wireless: Communicates with external devices via Bluetooth — no physical port needed.
• Battery: Charges wirelessly through the skin using an inductive charger.
• Surgical Robot: Neuralink developed a precision surgical robot (R1) to insert the flexible threads while avoiding blood vessels.

Clinical Progress

• PRIME Study (2024): First human participant (Noland Arbaugh, quadriplegic) received an N1 implant in January 2024. He demonstrated ability to control a computer cursor, play games, and browse the internet using thought alone.
• Thread Retraction: Some threads retracted from the brain tissue after implantation, reducing the number of effective electrodes. Neuralink adjusted the surgical approach.
• Second Patient (2024): A second participant received the implant with improved results.

Goals

• Near-Term: Restore digital autonomy to people with paralysis — cursor control, typing, device interaction.
• Medium-Term: Enable communication for people who cannot speak, restore motor control through brain-controlled prosthetics.
• Long-Term (Aspirational): Enhance human cognitive capabilities, achieve "AI symbiosis" where humans can keep pace with AI through direct neural interfaces.

Technical Challenges

• Longevity: Implants must function reliably for decades inside the brain — tissue response and electrode degradation are ongoing challenges.
• Bandwidth: Current implants record from ~1,000 electrodes. The brain has ~86 billion neurons — the gap is enormous.
• Safety: Brain surgery carries inherent risks including infection, hemorrhage, and tissue damage.
• Decoding: Translating raw neural signals into precise intentions requires sophisticated AI models that adapt over time.

Neuralink is the most high-profile BCI company but faces significant scientific, engineering, and regulatory hurdles before its more ambitious visions can be realized.